Capital Market Strategies’s Merck MRK Stock Holding History

Capital Market Strategies’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$212K	Sell	2,675 -1,658	-38%	-$132K	0.15%	125
2025 Q1	$389K	Sell	4,333 -84	-2%	-$7.84K	0.26%	75
2024 Q4	$439K	Buy	4,417 +6	+0.1%	+$619	0.25%	86
2024 Q3	$501K	Buy	4,411 +10	+0.2%	+$1.19K	0.3%	67
2024 Q2	$545K	Buy	4,401 +6	+0.1%	+$773	0.34%	55
2024 Q1	$580K	Buy	4,395 +2	+0%	+$247	0.44%	52
2023 Q4	$479K	Hold	4,393	–	–	0.42%	58
2023 Q3	$447K	Sell	4,393 -22	-0.5%	-$2.37K	0.45%	55
2023 Q2	$509K	Buy	+4,415	New	+$501K	0.47%	55
2023 Q1	–	Sell	-3,742	Closed	-$415K	–	96
2022 Q4	$415K	Buy	3,742 +2	+0.1%	+$204	0.45%	60
2022 Q3	$322K	Sell	3,740 -99	-3%	-$8.84K	0.36%	77
2022 Q2	$350K	Sell	3,839 -93	-2%	-$8.24K	0.37%	78
2022 Q1	$323K	Buy	3,932 +11	+0.3%	+$867	0.28%	95
2021 Q4	$301K	Buy	+3,921	New	+$312K	0.25%	107

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Market Strategies's MRK Position: Q2 2025 in Review

Capital Market Strategies reduced its Merck (MRK) stake by 38% in Q2 2025, selling an estimated $132K and leaving 2,675 shares worth $212K. The position accounts for 0.15% of the portfolio, ranked #125.

Capital Market Strategies first reported a position in MRK in Q4 2021 and has held it in 14 quarters since. The position peaked at $580K in Q1 2024. 3,332 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

Capital Market Strategies held 2,675 shares of Merck worth $212K as of Q2 2025.
Capital Market Strategies sold 1,658 Merck shares in Q2 2025, an estimated $132K.
Merck made up 0.15% of Capital Market Strategies's portfolio in Q2 2025, its #125 holding.
Capital Market Strategies first reported a position in Merck in Q4 2021 and has held it in 14 quarters since.
Capital Market Strategies's Merck position peaked at $580K in Q1 2024.
3,332 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Capital Market Strategies's 13F filing for Q2 2025, filed 2 Jul 2025.